{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:43:59Z","timestamp":1785545039932,"version":"3.56.0"},"reference-count":36,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are 2 of the leading causes of vision loss worldwide. As population aging and diabetes prevalence increase, timely detection of these conditions has become essential. However, limited professionalism and insufficient training in ophthalmic screening among general medicine physicians may lead to delayed diagnosis and treatment. Artificial intelligence (AI)\u2013assisted diagnostic tools may help to improve the screening of DR and AMD in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate the clinical effectiveness and cost-effectiveness of AI-assisted fundus imaging for DR and AMD screening in adults with diabetes and older adults at risk of macular degeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter, 2-arm, parallel-group, open-label, individual-level randomized controlled trial and patient recruitment are performed at the settings of Family Medicine and Geriatric and Gerontology Care over 4 medical centers in Taiwan. Eligibility includes (1) diabetic individuals aged \u226520 years for DR screening, and (2) individuals aged \u226550 years for AMD screening. The study protocol has been approved by the ethics committees of all participating hospitals, and all participants will provide written informed consent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study was funded in September 2024, began on October 2, 2025, and is expected to be completed in December 2027. After the pilot implementation phase without randomization, participants will be randomized 1:1 into two groups: (1) AI-assisted screening, and (2) usual physician-only screening. The primary outcomes will include the detection rates (defined as participants with confirmed DR or AMD among all screened participants) and the positive predictive values (defined as participants with confirmed DR or AMD among those who tested positive). Cost-effectiveness analyses will be performed using data derived from the trial results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study will provide robust evidence on the effectiveness of AI-assisted ophthalmic screening in improving patient eye health outcomes through timely screening and accurate early detection. This strategy may be cost-effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/91699","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:20:05Z","timestamp":1779873605000},"page":"e91699-e91699","source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence\u2013Assisted Screening for Patients With Diabetic Retinopathy and Age-Related Macular Degeneration in Family Medicine and Geriatric and Gerontology Care: Protocol for a Pragmatic Randomized Clinical Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5208-2292","authenticated-orcid":false,"given":"Bo-I","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-8541","authenticated-orcid":false,"given":"Ting-Ann","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-5825","authenticated-orcid":false,"given":"Teresa Cheng-Chieh","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-2243","authenticated-orcid":false,"given":"Ding-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-4140","authenticated-orcid":false,"given":"Shao-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4853-8665","authenticated-orcid":false,"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4639-1513","authenticated-orcid":false,"given":"Chu-Lin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-1216","authenticated-orcid":false,"given":"Yi-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5418-6507","authenticated-orcid":false,"given":"Chiuan-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-2414","authenticated-orcid":false,"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-4923","authenticated-orcid":false,"given":"John Tayu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-4458","authenticated-orcid":false,"given":"Chia-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-6207","authenticated-orcid":false,"given":"Patrick Yan-Tyng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-5142","authenticated-orcid":false,"given":"Chi-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-7986","authenticated-orcid":false,"given":"Chia-Ter","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-154X","authenticated-orcid":false,"given":"Yi-Ting","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Collaborators of AI Ophthalmology Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"17","key":"R1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","journal-title":"Eye Vis (Lond)"},{"issue":"9827","key":"R2","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","journal-title":"Lancet"},{"issue":"10153","key":"R3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","journal-title":"Lancet"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/a-2721-6552","article-title":"A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practice","volume":"58","author":"Chiang","journal-title":"Endoscopy"},{"issue":"22","key":"R5","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2016.17216","article-title":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs","volume":"316","author":"Gulshan","journal-title":"JAMA"},{"issue":"22","key":"R6","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2017.18152","article-title":"Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes","volume":"318","author":"Ting","journal-title":"JAMA"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjophthalmol-2018-313173","article-title":"Artificial intelligence and deep learning in ophthalmology","volume":"103","author":"Ting","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"R8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.22608\/APO.2019122","article-title":"Artificial intelligence in ophthalmology: accuracy, challenges, and clinical application","volume":"8","author":"Tan","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100875","article-title":"Artificial intelligence for the detection of age-related macular degeneration in color fundus photographs: a systematic review and meta-analysis","volume":"35","author":"Dong","journal-title":"EClinicalMedicine"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ophtha.2018.11.015","article-title":"DeepSeeNet: a deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs","volume":"126","author":"Peng","journal-title":"Ophthalmology"},{"issue":"7","key":"R11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ophtha.2017.02.008","article-title":"Automated identification of diabetic retinopathy using deep learning","volume":"124","author":"Gargeya","journal-title":"Ophthalmology"},{"issue":"8","key":"R12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ophtha.2018.01.023","article-title":"Efficacy of a deep learning system for detecting glaucomatous optic neuropathy based on color fundus photographs","volume":"125","author":"Li","journal-title":"Ophthalmology"},{"issue":"1 Pt 1","key":"R13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jfma.2020.03.024","article-title":"Application of deep learning image assessment software VeriSee for diabetic retinopathy screening","volume":"120","author":"Hsieh","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","DOI":"10.3390\/life11030200","article-title":"The clinical influence after implementation of convolutional neural network-based software for diabetic retinopathy detection in the primary care setting","volume":"11","author":"Li","journal-title":"Life (Basel)"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5779276","article-title":"Cross-camera external validation for artificial intelligence software in diagnosis of diabetic retinopathy","volume":"2022","author":"Tsai","journal-title":"J Diabetes Res"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.survophthal.2024.03.008","article-title":"A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: from possibility to reality","volume":"69","author":"Wu","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"R17","doi-asserted-by":"publisher","DOI":"10.2196\/37188","article-title":"Randomized controlled trials of artificial intelligence in clinical practice: systematic review","volume":"24","author":"Lam","journal-title":"J Med Internet Res"},{"issue":"10","key":"R18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.38114","article-title":"Diabetic retinopathy screening among federally qualified health center patients using point-of-care AI: DRES-POCAI: a trial protocol","volume":"8","author":"Diaz","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bjo-2025-327447","article-title":"Effectiveness of artificial intelligence-based diabetic retinopathy screening in primary care and endocrinology settings in Australia: a pragmatic trial","volume":"110","author":"Joseph","journal-title":"Br J Ophthalmol"},{"issue":"19","key":"R20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/jama.2024.14887","article-title":"Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial","volume":"332","author":"Lee","journal-title":"JAMA"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1053\/j.gastro.2021.01.008","article-title":"Community-based gastric cancer screening coupled with a national colorectal cancer screening program: baseline results","volume":"160","author":"Lee","journal-title":"Gastroenterology"},{"issue":"6","key":"R22","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41591-025-03668-w","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomized trials","volume":"31","author":"Chan","journal-title":"Nat Med"},{"issue":"4","key":"R23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","journal-title":"Ophthalmology"},{"issue":"9","key":"R24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","journal-title":"Ophthalmology"},{"issue":"10","key":"R25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss","volume":"119","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jfma.2024.12.008","article-title":"A deep learning approach for the screening of referable age-related macular degeneration - Model development and external validation","volume":"125","author":"Hsu","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"R27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"Long-term outcomes of adding lutein\/zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 Report 28","volume":"140","author":"Chew","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"R28","doi-asserted-by":"publisher","DOI":"10.3390\/ph16070927","article-title":"Visual outcomes of anti-VEGF treatment on neovascular age-related macular degeneration: a real-world population-based cohort study","volume":"16","author":"Korva-Gurung","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"R29","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1167\/iovs.08-1803","article-title":"Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study","volume":"49","author":"Chen","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.06.018","article-title":"2019 Diabetes Atlas: achievements and challenges in diabetes care in Taiwan","volume":"118 Suppl 2","author":"Hsu","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-37292-6","article-title":"Real-world performance of an AI system for diabetic retinopathy screening","volume":"16","author":"Berrada","journal-title":"Sci Rep"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(01)00307-2","article-title":"A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus","volume":"54 Suppl 1","author":"Chen","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"R33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-5491.2003.01019.x","article-title":"Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan","volume":"20","author":"Liu","journal-title":"Diabet Med"},{"issue":"5","key":"R34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/09286580600826637","article-title":"Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan","volume":"13","author":"Tung","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"R35","doi-asserted-by":"publisher","first-page":"100071","DOI":"10.1016\/j.apjo.2024.100071","article-title":"Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: a nationwide population-based propensity score-matched cohort study","volume":"13","author":"Chung","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"9","key":"R36","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jfma.2021.12.024","article-title":"Quality assurance of integrative big data for medical research within a multihospital system","volume":"121","author":"Lee","journal-title":"J Formos Med Assoc"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e91699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:24:06Z","timestamp":1785536646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e91699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2196\/91699","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"v15i17e91699"}}